AMWL

American Well Corp

8.78

+0.32+3.78%

After Hours: 8.63 -0.15 -1.71%16:21 06/04 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE8.43/8.46

TODAY RANGE8.43-8.98

VOL93.53K

MARKET CAP146.70M

52 WEEK RANGE3.710-9.96

AVG VOL (3M)71.31K

% TURNOVER0.56%

TURNOVER--

P/E (TTM)-1.6224

% RANGE5.73%

EPS(TTM)-5.4116

P/E(FORWARD)-2.6131

P/B0.6434

BVPS13.65

DIVIDEND--

P/S0.5786

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP120.29M

SHARES OUTSTANDING16.71M

NEXT EARNINGS08/03-08/07

FREE FLOAT13.70M

LOT SIZE1

EX-DATE07/11/2024

News

Press Releases

Financial Reports

Profile

TipRanks·20h ago
Top American Well Executives Quietly Cash In on Company Stock
TipRanks·05/12 13:36
American Well Co-Founder and Executive Vice Chairman Departs Board
TipRanks·05/11 02:38
American Well (AMWL) Receives a Hold from Stifel Nicolaus
TipRanks·05/07 07:37
Amwell price target raised to $6.50 from $6 at Morgan Stanley
TipRanks·05/07 00:37
Amwell Earnings Call Shows Cost Wins Amid Revenue Decline
Dow Jones·05/06 18:44
American Well Price Target Raised to $8.00/Share From $5.00 by TD Cowen
Dow Jones·05/06 18:44
American Well Is Maintained at Hold by TD Cowen
Dow Jones·05/06 16:36
American Well Price Target Raised to $6.50/Share From $6.00 by Morgan Stanley
Dow Jones·05/06 16:36
American Well Is Maintained at Equal-Weight by Morgan Stanley
TipRanks·05/06 13:40
Analysts Offer Insights on Healthcare Companies: Neurocrine (NBIX), Fresenius Medical Care (FMS) and American Well (AMWL)
TipRanks·05/06 10:35
Amwell Maintains Hold as Analyst Lifts Price Target to $6.50 Amid Improving Metrics but Unproven Growth Recovery
TipRanks·05/06 10:27
American Well Kept at Hold as Strong Q1 and Profit Progress Offset by Cautious Revenue Outlook and Government Contract Uncertainty
TipRanks·05/06 10:10
Analysts Have Conflicting Sentiments on These Healthcare Companies: Ultragenyx Pharmaceutical (RARE), American Well (AMWL) and Adaptive Biotechnologies (ADPT)
TipRanks·05/06 10:00
Analysts Conflicted on These Healthcare Names: American Well (AMWL), Adaptive Biotechnologies (ADPT) and Ultragenyx Pharmaceutical (RARE)
Seeking Alpha·05/06 06:02
Amwell outlines 2026 adjusted EBITDA loss of $16M to $12M while targeting Q4 cash flow breakeven

Same Industry

Name/Symbol

Change%

Price

American Well Corp

AMWL

+3.78%

8.78

Hca Healthcare Inc

HCA

-1.52%

378.54

Chemed Corp

CHE

-3.06%

426.41

Univ Health Svc

UHS

-2.67%

146.11

LH-WI

Labcorp Holdings Inc

-0.75%

260.06

AMN

DGX

Davita Inc

DVA

+0.04%

189.89

Tenet Healthcare Corp

THC

+1.22%

175.32

ENSG

Corvel Corp

CRVL

+0.18%

61.75

Addus Homecare Corp

ADUS

-1.98%

91.68

CVS

ACHC

EHC

Encompass Health

EHC-WI

0.00%

44.40

USPH

PINC

ENSGV

SEM

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.